AG NPP709 is currently available on the market; however, no review has investigated the impact of AG NPP709 in patients with COPD. Therefore, the goal of the study was to evaluate the efficacy of AG NPP709 in patients with Continual bronchitis kind COPD.Berberine suppresses inflammatory brokers-induced interleukin-1beta and tumor necrosis factor-al